مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma.
Normal view MARC view ISBD view

Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma. [electronic resource]

By:
  • Tari, Akira
Contributor(s):
  • Kitadai, Yasuhiko
  • Mouri, Ritsuo
  • Takigawa, Hidehiko
  • Asaoku, Hideki
  • Mihara, Keiichiro
  • Takata, Katsuyoshi
  • Fujihara, Megumu
  • Yoshino, Tadashi
  • Koga, Tadashi
  • Fujimori, Shunji
  • Tanaka, Shinji
  • Chayama, Kazuaki
Producer: 20180820Description: 1461-1468 p. digitalISSN:
  • 1440-1746
Subject(s):
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
  • Asian People
  • Cyclophosphamide -- administration & dosage
  • Disease-Free Survival
  • Doxorubicin -- administration & dosage
  • Female
  • Humans
  • Intestinal Neoplasms -- pathology
  • Lymphoma, Follicular -- pathology
  • Male
  • Middle Aged
  • Prednisone -- administration & dosage
  • Prospective Studies
  • Rituximab -- administration & dosage
  • Treatment Outcome
  • Tumor Burden
  • Vincristine -- administration & dosage
  • Watchful Waiting
Online resources:
  • Available from publisher's website
In: Journal of gastroenterology and hepatology vol. 33
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma.

APA

Tari A., Kitadai Y., Mouri R., Takigawa H., Asaoku H., Mihara K., Takata K., Fujihara M., Yoshino T., Koga T., Fujimori S., Tanaka S. & Chayama K. (20180820). Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma. : Journal of gastroenterology and hepatology.

Chicago

Tari Akira, Kitadai Yasuhiko, Mouri Ritsuo, Takigawa Hidehiko, Asaoku Hideki, Mihara Keiichiro, Takata Katsuyoshi, Fujihara Megumu, Yoshino Tadashi, Koga Tadashi, Fujimori Shunji, Tanaka Shinji and Chayama Kazuaki. 20180820. Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma. : Journal of gastroenterology and hepatology.

Harvard

Tari A., Kitadai Y., Mouri R., Takigawa H., Asaoku H., Mihara K., Takata K., Fujihara M., Yoshino T., Koga T., Fujimori S., Tanaka S. and Chayama K. (20180820). Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma. : Journal of gastroenterology and hepatology.

MLA

Tari Akira, Kitadai Yasuhiko, Mouri Ritsuo, Takigawa Hidehiko, Asaoku Hideki, Mihara Keiichiro, Takata Katsuyoshi, Fujihara Megumu, Yoshino Tadashi, Koga Tadashi, Fujimori Shunji, Tanaka Shinji and Chayama Kazuaki. Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma. : Journal of gastroenterology and hepatology. 20180820.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site